Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2014


European Statistical Forum 2014

17 Nov 2014 - 17 Nov 2014 - Brussels, Belgium



Bookmark and Share


The EUROPEAN STATISTICAL FORUM is pleased to announce its 5th Annual Conference:

The current status of the application of Bayesian Methods in Drug Development

In the last years the biostatistics community has increased its interest in the application of Bayesian methodology in drug development as it provides a framework for determining probabilities relevant to inferences from current trials and previous knowledge.

Bayesian statistics has the potential to play an important role throughout the drug/device development process lifecycle and in particular in the decision-making process. Its range of applications contains early phase studies, dose-finding, safety analyses, meta-analyses, decision theory as well as the quantification of the benefits and risks essential to health economic evaluation. While the use of Bayesian methodologies has significantly increased in the recent years in exploratory clinical trials, its use in confirmatory clinical trials is still not common.

The fifth edition of the European Statistical Forum is dedicated to Bayesian Statistics, in particular by presenting:

  •  Current state-of-art implementation in clinical trials
  •  Recent enhancements in the methodology
  •  Regulatory perspectives on its application in clinical trials.

The conference aims at promoting the exchange of expertise in the field coming from academia and industry as well as regulators.

The Scientific Board:

  • Jens-Otto Andreas, Director, Head Global Biostatistics EU Group, UCB BIOSCIENCES GmbH
  • Lisa Comarella, Director, Biostatistics, Senior Project Manager, Cros NT Group
  • Frank Fleischer, Global BCA, Boehringer Ingelheim Pharma GmbH & Co. KG
  • Giacomo Mordenti, Senior Director Compound Development & Branding-Head Biostatistics, Grünenthal 

will share best practices, results and experiences in this field.

Who should attend?

The conference is addressed to Statisticians and Professionals with a deep interest in the application of Bayesian methodology in clinical trials belonging to: Pharmaceutical, Biotechnology and related Industries, CROs, Academy, Hospital Centres, University.

Pre-Conference Dinner at Aux Armes de Bruxelles, Brussels

Sunday, 16th November, 7:30 pm

For further information, please visit: www.esforum.eu




Further information
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!